Scientists have discovered how a potent bacterial toxin is able to target and kill MRSA, paving the way for potential new treatments for superbugs.
New research has explained how lysostaphin specifically recognises MRSA cell walls and quickly causes the breakdown of this pathogen. The lysostaphin is able to increase the number of its molecules bound to the surface of the MRSA cell and this allows the enzyme to 'walk' along the cell walls and cause rapid breakdown.
Lysostaphin is an enzyme that has been shown to eradicate Staphylococcal infections, such as MRSA, alone or in combination with antibiotics. Although it was discovered over 50 years ago, not much has been known about how it kills these infections.
The C-terminal SH3b domain of lysostaphin recognizes peptidoglycans containing a pentaglycine crossbridge and has been proposed to drive the preferential digestion of staphylococcal cell walls. The authors show that the pentaglycine crossbridge and the peptide stem are recognized by two independent binding sites located on opposite sides of the SH3b domain, thereby inducing a clustering of SH3b domains.
The scientists hope to use their findings to develop new treatments for MRSA and other antibiotic resistant superbugs which target the infection in a similar way. MRSA is a bacterial superbug that is resistant to several antibiotics and frequently spreads in hospitals where people are more susceptible to infection.
The senior author said: "Lysostaphin is arguably the most studied enzyme after lysozyme, so we are delighted that our research is able to explain the mechanism underpinning its potent antibacterial activity.
"Our study explains how this enzyme is able to target and digest the MRSA bacteria and why it is so potent. Hospital-acquired infections caused by bacteria resistant to last resort antibiotics are on the rise, but our work could lead to the development of new treatments for these superbugs that use the same targeting mechanism."
The paper is published \in Nature Chemical Biology.
https://www.sheffield.ac.uk/news/nr/scientists-discover-bacteria-toxin-kills-mrsa-1.871287
https://www.nature.com/articles/s41589-019-0393-4?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+nchembio%2Frss%2Fcurrent+%28Nature+Chemical+Biology+-+Issue%29
How potent bacterial toxin kills MRSA bacteria
- 1,732 views
- Added
Edited
Latest News
Paranoia in the brain
By newseditor
Posted 16 Jun
In-vitro 3D culture of func…
By newseditor
Posted 15 Jun
Neural balance in the brain…
By newseditor
Posted 15 Jun
Antimalarial compounds reli…
By newseditor
Posted 15 Jun
3D imaging of whole human b…
By newseditor
Posted 14 Jun
Other Top Stories
A novel method for monitoring the effect of lung cancer therapy
Read more
Gene screening technique called Sleeping Beauty mutagenesis detects…
Read more
Src regulates mTOR to control cancer growth
Read more
Critical cancer immunity genes identified using new genetic barcodi…
Read more
Esophageal cells accumulate thousands of mutations over time!
Read more
Protocols
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Publications
NRG1-ErbB4 signaling in the…
By newseditor
Posted 15 Jun
HPV integration and cervica…
By newseditor
Posted 15 Jun
Cerebral tau pathology in c…
By newseditor
Posted 15 Jun
Cerebral tau pathology in c…
By newseditor
Posted 15 Jun
Synthetic biodegradable mic…
By newseditor
Posted 15 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar